Quantum Private Wealth’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,238
Closed -$214K 191
2024
Q1
$214K Buy
+2,238
New +$188K 0.08% 165
2023
Q4
Sell
-3,627
Closed -$251K 182
2023
Q3
$251K Sell
3,627
-2,820
-44% -$227K 0.12% 150
2023
Q2
$608K Buy
6,447
+3,794
+143% +$330K 0.28% 84
2023
Q1
$219K Buy
+2,653
New +$209K 0.12% 167
2022
Q4
Sell
-2,902
Closed -$239K 189
2022
Q3
$239K Sell
2,902
-2,116
-42% -$204K 0.15% 146
2022
Q2
$477K Sell
5,018
-28,643
-85% -$2.97M 0.28% 84
2022
Q1
$3.96M Sell
33,661
-1,400
-4% -$157K 1.71% 11
2021
Q4
$4.54M Buy
+35,061
New +$4.09M 1.72% 9

Other funds holding EW

Quantum Private Wealth's EW Position: Q2 2024 in Review

Quantum Private Wealth sold out of Edwards Lifesciences (EW) in Q2 2024, closing a stake of 2,238 shares — an estimated $214K sold.

Quantum Private Wealth first reported a position in EW in Q4 2021 and held it in 8 quarters. The position peaked at $4.54M in Q4 2021. 1,296 funds tracked by Wall St. Rank hold EW as of Q2 2024.

  • Quantum Private Wealth reported no remaining Edwards Lifesciences position as of Q2 2024 after selling out during the quarter.
  • Quantum Private Wealth sold 2,238 Edwards Lifesciences shares in Q2 2024, an estimated $214K.
  • Quantum Private Wealth first reported a position in Edwards Lifesciences in Q4 2021 and held it in 8 quarters.
  • Quantum Private Wealth's Edwards Lifesciences position peaked at $4.54M in Q4 2021.
  • 1,296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Quantum Private Wealth's 13F filing for Q2 2024, filed 17 Jul 2024.